Kymera Therapeutics (KYMR) PT Raised to $125 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: KYMR) | Delayed: 131.48 +3.97 (3.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.51 | 52 Week High | $ | |||
| Open | $128.79 | 52 Week Low | $ | |||
| Day High | $133.88 | P/E | N/A | |||
| Day Low | $127.95 | EPS | $ | |||
| Volume | 267,955 | |||||
